Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9872115 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 9 Pages |
Abstract
Conclusions: It was concluded that HDR brachytherapy combined with hypofractionated EBRT is feasible for localized prostate cancer when considered from the viewpoint of acute toxicity. Increase in the fraction dose or reduction in the number of fractions in HDR brachytherapy did not affect the severity of acute GU toxicity, and the volume of urethra receiving an equal or lower radiation dose than the prescribed dose was more closely associated with the grade severity of acute GU toxicity than that receiving a higher than the prescribed dose.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Tetsuo M.D., Ph.D., Kazuto M.D., Ph.D., Jun-ichi M.D., Ph.D., Shin-ei M.D., Koichi M.D., Hideyuki M.D., Ph.D., Yuko M.D., Ph.D., Takumi M.D., Kazuhiro M.D., Ph.D., Takashi M.D., Ph.D., Hideo M.D., Ph.D.,